Related Experiment Video
Updated: Jan 5, 2026
08:52
Evaluation of Host-Pathogen Responses and Vaccine Efficacy in Mice
Published on: February 22, 2019
11.1K
Vaccines for emerging pathogens: from research to the clinic. Part two
1CBR Division, Defence Science and Technology Laboratory, Porton Down Salisbury, Wiltshire, UK.
Clinical and Experimental Immunology
|October 19, 2019
Summary
This review covers vaccine development for emerging pathogens, focusing on formulation, delivery, and licensure prospects for new vaccines. It highlights advancements in creating effective vaccines against viral and bacterial threats.
Area of Science:
- Immunology
- Vaccinology
- Infectious Diseases
Background:
- This review is Part Two of a series on vaccine research and development for emerging pathogens.
- It follows Part One, which covered progress in viral and bacterial vaccines.
Discussion:
- This part emphasizes the critical role of vaccine formulation in efficacy.
- It also discusses the importance of selecting appropriate delivery vehicles for vaccine candidates.
- The prospects for the licensure of current vaccine candidates are also considered.
Key Insights:
- Vaccine formulation and delivery systems are crucial for developing effective vaccines against emerging pathogens.
- Current candidate vaccines show promise for future licensure.
Outlook:
- Continued research into novel vaccine formulations and delivery systems is essential.
- Further development and clinical trials are needed to bring new vaccines to licensure.
Related Concept Videos
01:29Microorganisms in Medicine and Therapeutics
905
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
905
01:51Vaccinations
51.1K
Overview
51.1K
01:30Cancer Vaccines
913
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
913
01:28Preclinical Development: Overview
5.7K
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
5.7K
01:22Development of Immunocompetence
745
The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
745
01:29Immune Response Against Viral Pathogens
1.6K
The immune system's response to viral infections is a complex and coordinated process involving natural killer (NK) cells, T cell-mediated responses, and antibody-mediated responses.
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
1.6K